Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 7, 2007, Pages 1070-1076

  Jain, Ayushi ^a   Sharma, Mehar Chand ^a   Sarkar, Chitra ^a   Bhatia, Rohit ^a   Singh, Sumit ^a   Handa, Rohini ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCLUSION BODY MYOSITIS; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MYOPATHY; NEUROMUSCULAR DISEASE; POLYMYOSITIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUSCLES; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; RETROSPECTIVE STUDIES;

EID: 34447322580     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1994; 292:344-347.
2. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Narden, The Netherlands. Neuromuscul Disord. 2004;14:337-345.
3. Engel AG, Hohlfeld R, Banker BQ. Inflammatory myopathies: the polymyositis and dermatomyostis syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology. New York, NY: McGraw Hill Publishing; 2004:1335-1383.
4. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003; 362:971-982.
5. Civatte M, Schleinitz N, Krammer P, et al. Class I MHC expression as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM). Neuropathol Appl Neurobiol. 2003;29:546-552.
6. Appleyard ST, Dunn MZ, Dubowitz V, Rose ML. Increased expression of HLA-ABC class I antigens by muscle fibers in duchenne muscular dystrophy, inflammatory myopathy and other neuromuscular disorders. Lancet. 1985;i:361-363.
7. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of HLA-A,B,C antigens in normal human organs. Transplantation. 1984;38:287-292.
8. Nagaraju K, Raben N, Loeffler L, et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A. 2000;97:9209-9214.
9. Bartoccioni E, Gallucci S, Scuderi F, et al. MHC Class I, II and Intercellular adhesion molecule-I (ICAM-I) expression in inflammatory myopathies. Clin Exp Immunol. 1994;95:166-172.
10. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T-cell mediated cytotoxicity in myopathies. Hum Pathol. 1989;20:224-331.
11. Isenberg DA, Rowe D, Shearer M, et al. Localization of interferons and interleukin-2 in polymyositis and muscular dystrophy. Clin Exp Immunol. 1986; 63:450-458.
12. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive MHC products in human skeletal muscles. Ann Neurol. 1988;23:64-72.
13. McDouall RM, Dunn MJ, Dubowitz V. Expression of class I and II MHC antigens in neuromuscular diseases. J Neurol Sci. 1989;89:213-226.
14. Olsson T, Henriksson KG, Klareskog L, Forsum U. HLA-DR expression, T lymphocyte phenotypes, OKM-1 and OKT9 reactive cells in inflammatory myopathy. Muscle Nerve. 1985;8:419-425.
15. Rowe D, Isenberg DA, Beverley PCL. Monoclonal antibodies to immune leukocyte antigens in polymyositis and muscular dystrophy. Clin Exp Immunol. 1983;54:327-336.
16. van der Pas J, Hengstman GJD, ter Laak HJ, Borm GF, van Engelen BGM. Diagnostic value of MHC Class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2004;75:136-139.
17. Dalakas MC, Hohlfeld R. Diagnostic criteria of polymyositis and Inclusion body myositis. Lancet. 2003;362:1762-1763.
18. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med. 1991;325:1487-1498.
19. Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomysositis and inclusion body myositis. Curr Opin Neurol. 2004;17:561-567.